Results · Apr-Jun 2026
Corona Remedies Q1 FY27 results
Sales were ₹422 crore & net profit ₹60.1 crore. The same quarter last year is not in our data, so there is no comparison yet.
Against Jan-Mar 2026: sales +20%, net profit +33%.
The last 4 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.